secwatch.observer — SEC 8-K summary
======================================

Issuer:     BiomX Inc. (PHGE)
CIK:        0001739174
Form:       8-K
Filed at:   2026-04-13T23:59:59+00:00
Accession:  0001213900-26-042811
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BiomX accelerates option exercise, acquires 60% stake in DFSL for $750k cash, $3M note
--------------------------------------------------------------------------------

- Cash $750k, $3M convertible note (convertible at $12), 923k shares, and warrants for up to 4.6M shares at $12.
- Revenue bonus: 5% of annual revenues if DFSL exceeds $25M in any fiscal year from 2027; payable in stock or cash.
- DFSL develops LADAR-based detection systems for counter-UAS and perimeter security; deployed in Israel, Africa, and LA Metro.
- Transaction subject to Israeli regulatory approval and NYSE American stockholder approval.
- Acquisition follows prior purchase of Zorronet AI platform; technologies designed to integrate detection, analysis, and response.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026042811/0001213900-26-042811-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026042811/ea0285293-8k_biomx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-042811

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer